Plaque Erosion: A New in Vivo Diagnosis and Paradigm Shift in the Treatment of Patients With Acute Coronary Syndrome

Trial Profile

Plaque Erosion: A New in Vivo Diagnosis and Paradigm Shift in the Treatment of Patients With Acute Coronary Syndrome

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Aspirin (Primary) ; Heparin (Primary) ; Ticagrelor (Primary)
  • Indications Acute coronary syndromes
  • Focus Proof of concept; Therapeutic Use
  • Acronyms EROSION
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 28 Oct 2016 New trial record
    • 30 Aug 2016 Primary endpoint (Reduction of thrombus burden by OCT) has been met, according to results published in the European Heart Journal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top